Suppr超能文献

伴有腹水的持续性非卧床腹膜透析(CAPD)患者溶质转运速率与引流液量之间的差异。

Discrepancy between solute transport rate and drain volume in CAPD patients with ascites.

作者信息

Yoon S N, Yang C W, Lee S H, Kim Y S, Choi E J, Chang Y S, Bang B K

机构信息

Department of Internal Medicine, Catholic University Medical College, Seoul, Korea.

出版信息

Adv Perit Dial. 1996;12:39-42.

PMID:8865869
Abstract

The ascites in the chronic renal failure patient is often difficult to treat and becomes intractable. Continuous ambulatory peritoneal dialysis (CAPD), as a maintenance therapy, is effective in the removal of ascites and may become a good alternative in dialysis therapy. The aim of this study was to evaluate the peritoneal membrane transport characteristics and ultrafiltration rate in CAPD patients who had preexisting ascites. Seven CAPD patients (6 male, 1 female; mean age 43 +/- 11 years) were included. The causes of ascites were liver cirrhosis (n = 4), hemodialysis-associated process (n = 2), and heart failure (n = 1). A peritoneal equilibration test (PET) using 2.5% dialysate was performed by the standard method at ten days after starting CAPD. The solute transport rate [dialysate glucose ratio (D/D6) and dialysate-to-plasma creatinine concentration ratio] showed high (n = 5) or high average (n = 2) transport. In 5 patients with high transport, PET showed a discrepancy between solute transport rate and drain volume. In spite of the high transport rate, the drain volume was greater than expected and corresponded to the area of low average or high average solute transport rate. Considering adequate solute clearance and good ultrafiltration, CAPD is an effective treatment in end-stage renal disease patients with intractable ascites.

摘要

慢性肾衰竭患者的腹水往往难以治疗且会变得棘手。持续性非卧床腹膜透析(CAPD)作为一种维持性治疗方法,在消除腹水上是有效的,并且可能成为透析治疗中的一个良好选择。本研究的目的是评估已有腹水的CAPD患者的腹膜转运特性和超滤率。纳入了7例CAPD患者(6例男性,1例女性;平均年龄43±11岁)。腹水的病因包括肝硬化(n = 4)、血液透析相关过程(n = 2)和心力衰竭(n = 1)。在开始CAPD十天后,采用标准方法使用2.5%透析液进行腹膜平衡试验(PET)。溶质转运率[透析液葡萄糖比率(D/D6)和透析液与血浆肌酐浓度比率]显示为高转运(n = 5)或高平均转运(n = 2)。在5例高转运患者中,PET显示溶质转运率与引流液量之间存在差异。尽管转运率高,但引流液量大于预期,且与低平均或高平均溶质转运率区域相对应。考虑到足够的溶质清除和良好的超滤,CAPD是治疗终末期肾病合并顽固性腹水患者的有效方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验